Literature DB >> 28365967

Complete response to crizotinib in a patient with adenocarcinoma of the lung cancer harboring c- MET amplification.

Ibrahim Cil1, Alisan Zirtiloglu, Nurbanu Saydam, Deniz Tural.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28365967

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


× No keyword cloud information.
  1 in total

1.  Responses to crizotinib can occur in c-MET overexpressing nonsmall cell lung cancer after developing EGFR-TKI resistance.

Authors:  Yanjun Xu; Yun Fan
Journal:  Cancer Biol Ther       Date:  2018-11-13       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.